Keyphrases
Erectile Dysfunction
100%
Phosphodiesterase Type V Inhibitors
100%
Udenafil
100%
Placebo
41%
International Index of Erectile Function
41%
Change from Baseline
33%
Global Assessment
25%
Domain Scores
25%
Assessment Questions
25%
Fixed-dose Combination
16%
Patient Response
16%
Function Domain
16%
Erectile Function
16%
Headache
8%
Adverse Events
8%
Treatment Group
8%
Placebo Groups
8%
Phase II Trial
8%
Etiology
8%
Moderate to Severe
8%
Placebo-controlled
8%
Great Changes
8%
Treatment-related Adverse Events
8%
SEP3
8%
Facial Flushing
8%
Responses to Questions
8%
Sexual Encounters
8%
Medicine and Dentistry
Erectile Dysfunction
100%
Phosphodiesterase V Inhibitor
100%
Udenafil
100%
Placebo
58%
Adverse Event
16%
Headache
8%
Pharmacology, Toxicology and Pharmaceutical Science
Erectile Dysfunction
100%
Phosphodiesterase V Inhibitor
100%
Udenafil
100%
Placebo
58%
Adverse Event
16%
Headache
8%